MARIA SARGENT: Open Payments
NPI 1023191392 · GRAYSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 63 payments from 16 companies in 2025. Trend: 2023 $996 · 2024 $1,587 · 2025 $1,098
Food & beverage: $1,098
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $172 |
| AstraZeneca Pharmaceuticals LP | 6 | $151 |
| Novo Nordisk Inc | 8 | $145 |
| ABBVIE INC. | 5 | $103 |
| Corcept Therapeutics | 4 | $70 |
| Exact Sciences Corporation | 3 | $49 |
| PFIZER INC. | 3 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $34 |
Products named: CAPLYTA, TRELEGY ELLIPTA, VRAYLAR, FARXIGA, Korlym, Wegovy, BREZTRI, Cologuard Collection Kit.
Industry payments across KY — which companies pay providers there.
